Skip to content
Table S2 from Phase Ib Study of Immunocytokine Simlukafusp Alfa (FAP-IL2v) Combined with Pembrolizumab for Treatment of Advanced and/or Metastatic Melanoma — Eva Muñoz‐Couselo (2025) | RDL Network